NCT06056323 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06056323
Title	A Study of HB0045 Injection in Patients With Advanced Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Shanghai Huaota Biopharmaceutical Co., Ltd.
Indications	hepatocellular carcinoma lung cancer breast cancer fallopian tube cancer prostate cancer Advanced Solid Tumor ovary epithelial cancer colorectal cancer kidney cancer pancreatic ductal adenocarcinoma endometrioid ovary carcinoma pancreatic cancer sarcoma head and neck cancer peritoneum cancer ovarian cancer ovarian clear cell carcinoma
Therapies	HB0045
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Dana-Farber Cancer Institute	NOT_YET_RECRUITING	Boston	Massachusetts	02215	United States	Details
The Gabrail Pharmacology Phase 1 Research Center LLC	RECRUITING	Canton	Ohio	44718	United States	Details
UT M.D. Anderson Cancer Center	NOT_YET_RECRUITING	Houston	Texas	301402	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06056323Clinical Trial Detail